{"AllianceGenome": "280", "HGNC": "280", "MIM": "104219", "_id": "146", "_version": 1, "accession": {"genomic": ["AL121675.36", "AL357040.14", "CH471133.3", "CP068258.2", "D29952.1", "EU326302.1", "NC_000020.11", "NC_060944.1"], "protein": ["AAB31163.2", "AAB59487.1", "AAB60351.1", "ACA05908.1", "BAA06222.1", "EAX10455.1", "NP_000669.1", "P25100.2"], "rna": ["L31772.1", "NM_000678.4", "S70782.1", "U03864.1"], "translation": [{"protein": "AAB59487.1", "rna": "L31772.1"}, {"protein": "NP_000669.1", "rna": "NM_000678.4"}, {"protein": "AAB31163.2", "rna": "S70782.1"}, {"protein": "AAB60351.1", "rna": "U03864.1"}]}, "alias": ["ADRA1", "ADRA1A", "ADRA1R", "ALPHA1", "DAR", "dJ779E11.2"], "ensembl": {"gene": "ENSG00000171873", "protein": "ENSP00000368766", "transcript": ["ENST00000379453", "ENST00000621688"], "translation": [{"protein": "ENSP00000368766", "rna": "ENST00000379453"}], "type_of_gene": "protein_coding"}, "entrezgene": "146", "exons": [{"cdsend": 4248957, "cdsstart": 4221522, "chr": "20", "position": [[4220629, 4222130], [4247846, 4249287]], "strand": -1, "transcript": "NM_000678", "txend": 4249287, "txstart": 4220629}], "exons_hg19": [{"cdsend": 4229604, "cdsstart": 4202169, "chr": "20", "position": [[4201276, 4202777], [4228493, 4229934]], "strand": -1, "transcript": "NM_000678", "txend": 4229934, "txstart": 4201276}], "generif": [{"pubmed": 12409310, "text": "Data show thah activation of alpha(1)A- or alpha(1)B-adrenergic receptors inhibits serum-promoted cell proliferation, whereas alpha(1)D-AR activation does not show such an inhibitory effect."}, {"pubmed": 12442007, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14626446, "text": "These studies suggest that gC1qR interacts specifically with alpha1B- and alpha1D-, but not alpha1A-ARs, and this interaction depends on the presence of an intact C-tail."}, {"pubmed": 14736874, "text": "cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors"}, {"pubmed": 15297446, "text": "alpha(1A)- and alpha(1D)-adrenergic receptors mediate G(1)-S cell-cycle arrest"}, {"pubmed": 15690361, "text": "Human ureter was endowed with each alpha1 AR subtype, although alpha1D and alpha1A ARs were prevalent over alpha1B ARs."}, {"pubmed": 16533813, "text": "alpha1D-adrenergic receptors are regulated by syntrophins through a PDZ domain-mediated interaction"}, {"pubmed": 17384146, "text": "Differential methylation of proximal GC boxes in the ADRA1D promoter disrupts Sp1 binding in a cell-specific manner resulting in repression of basal alpha1dAR expression."}, {"pubmed": 17404580, "text": "ADRA1D polymorphisms are predictive markers of the response to beta-blockers"}, {"pubmed": 17404580, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17660397, "text": "Stimulation of alpha(1D)-ARs by picomolar phenylephrine concentrations devoid of any contractile vascular effects, induces a proangiogenic phenotype in endothelial cells that is enhanced in a hypoxic environment."}, {"pubmed": 17681068, "text": "In the proximal and medial ureter, the distribution of ARs was alpha 1d > or = alpha 1a > alpha 1b; In the distal ureter, the distribution of ARs was alpha 1d > alpha 1a > alpha 1b"}, {"pubmed": 17973108, "text": "expression in distal ureter higher than in proximal and mid ureter but not statistically significant"}, {"pubmed": 18187928, "text": "Investigate role of ADRA1D amino residues in binding of beta-adrenergic antagonists (prazosin/tamulosin)."}, {"pubmed": 18257748, "text": "ADRA1A expression was decreased in end stage renal disease. Functional receptor changes mediated vascular hypersensitivity to phenylephrine."}, {"pubmed": 18628404, "text": "ADRA1D induces vascular smooth muscle apoptosis via a p53-dependent mechanism."}, {"pubmed": 19086053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19458937, "text": "Our data indicate that carboxyl terminus-truncated alpha(1D)-adrenoceptors are fully functional and subjected to regulation by phosphorylation. The roles of the carboxyl termini differ among alpha(1)-adrenoceptor subtypes."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21063774, "text": "Genetic characteristics associated with response to domperidone therapy included polymorphisms in the drug transporter gene ABCB1, the potassium channel KCNH2 gene, and alpha1D--adrenoceptor ADRA1D gene."}, {"pubmed": 21063774, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21115837, "text": "Data show that alpha-dystrobrevin-1 recruits alpha-catulin, which supersensitizes alpha(1D)-AR functional responses by recruiting effector molecules to the signalosome."}, {"pubmed": 23205498, "text": "alpha(1)(D)-adrenoceptors in the lower urinary tract might play an important role in the pathophysiology of lower urinary tract disorders. [review]"}, {"pubmed": 23877383, "text": "Mean alpha-receptor stain rates in renal pelvis were 2.65 +/- 0.74, 1.35 +/- 0.81 and 2.9 +/- 0.30 for alpha 1A, 1B and 1D, respectively. For calyces, the rates are 2.40 +/- 0.82, 1.50 +/- 0.76 and 2.75 +/- 0.44 for alpha 1A, 1B and 1D, respectively."}, {"pubmed": 24844469, "text": "alpha1A-adrenergic receptors are stably expressed and stimulate cell migration and TGF-beta1, IGF-1, hyaluronan and PIP production in human skin fibroblasts."}, {"pubmed": 25481381, "text": "Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation."}, {"pubmed": 26381449, "text": "This study showed that ADRA1D gene involved in neuronal growth and cerebellum development and associated with neurological and psychological disorders."}, {"pubmed": 26621245, "text": "In conclusion, our work clarified some cellular aspects promoted by alpha1D-AR activity modulation and supports a further pharmacological approach in the cure of hormone-refractory PC, by targeting specifically this AR subtype"}, {"pubmed": 26739946, "text": "Immunoreactivity for ADRA2D was densely distributed in submucosal glands of nasal turbinates."}, {"pubmed": 27146292, "text": "expression of carboxyl terminus-truncated alpha1D-adrenoceptors alters ERK and p38 phosphorylation state."}, {"pubmed": 27382054, "text": "processing of the ADRA1D NT domain is a physiological mechanism employed by cells to generate a functional ADRA1D isoform with optimal pharmacodynamic properties."}, {"pubmed": 28862946, "text": "Hetero-oligomerization of a1B/D-adrenergic receptor with the chemokine (C-X-C motif) receptor 4:atypical chemokine receptor 3 heteromeric complex is required for a1B/Dadrenergic receptor function."}, {"pubmed": 29089212, "text": "ADRA1 expression was greater on vascular smooth muscle in burn scars than in unscarred tissue, and greater on dermal nerve fibres, blood vessels and fibroblasts in keloid scars than in either burn scars or unscarred skin."}, {"pubmed": 30419287, "text": "The roles of adrenoceptor alpha 1D phosphorylation sites/clusters were investigated. Carboxyl terminus phosphorylation seems to control receptor's membrane localization. Intracellular loop 3 mutation caused agonist-induced sustained ERK1/2 activation."}, {"pubmed": 32085899, "text": "Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and alpha1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays."}, {"pubmed": 32350295, "text": "N-glycosylation of alpha1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis."}, {"pubmed": 37571902, "text": "Functional Involvement of ADRA1D in Cutaneous Melanoma Progression and Angiogenesis."}], "genomic_pos": {"chr": "20", "end": 4249287, "ensemblgene": "ENSG00000171873", "start": 4220630, "strand": -1}, "genomic_pos_hg19": {"chr": "20", "end": 4229721, "start": 4201329, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007186", "pubmed": 1656955, "qualifier": "involved_in", "term": "G protein-coupled receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007188", "pubmed": 10820200, "qualifier": "involved_in", "term": "adenylate cyclase-modulating G protein-coupled receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007200", "qualifier": "involved_in", "term": "phospholipase C-activating G protein-coupled receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007204", "qualifier": "involved_in", "term": "positive regulation of cytosolic calcium ion concentration"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007267", "qualifier": "involved_in", "term": "cell-cell signaling"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008284", "pubmed": 10860850, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043410", "qualifier": "involved_in", "term": "positive regulation of MAPK cascade"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045907", "qualifier": "involved_in", "term": "positive regulation of vasoconstriction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0071880", "qualifier": "involved_in", "term": "adenylate cyclase-activating adrenergic receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0150099", "qualifier": "involved_in", "term": "neuron-glial cell signaling"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0004937", "qualifier": "enables", "term": "alpha1-adrenergic receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16533813, 18468998, 21115837, 24550280, 26460884, 26617989, 27382054], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [14645668, 26617989, 27382054], "qualifier": "enables", "term": "identical protein binding"}]}, "homologene": {"genes": [[7955, 568614], [8364, 100495969], [9031, 422933], [9544, 100430996], [9598, 469869], [9606, 146], [9913, 539543], [10090, 11550], [10116, 29413]], "id": 551}, "interpro": [{"desc": "G protein-coupled receptor, rhodopsin-like", "id": "IPR000276", "short_desc": "GPCR_Rhodpsn"}, {"desc": "Alpha 1D adrenoceptor", "id": "IPR000363", "short_desc": "ADRA1D_rcpt"}, {"desc": "Adrenoceptor family", "id": "IPR002233", "short_desc": "ADR_fam"}, {"desc": "GPCR, rhodopsin-like, 7TM", "id": "IPR017452", "short_desc": "GPCR_Rhodpsn_7TM"}], "ipi": "IPI00012725", "map_location": "20p13", "name": "adrenoceptor alpha 1D", "other_names": ["adrenergic, alpha -1D-, receptor", "adrenergic, alpha-1A-, receptor", "alpha-1A adrenergic receptor", "alpha-1D adrenergic receptor", "alpha-1D adrenoceptor", "alpha-1D adrenoreceptor", "alpha-adrenergic receptor 1a"], "pantherdb": {"HGNC": "280", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "106673", "ortholog_type": "LDO", "panther_family": "PTHR24248", "taxid": 10090, "uniprot_kb": "P97714"}, {"RGD": "62064", "ortholog_type": "LDO", "panther_family": "PTHR24248", "taxid": 10116, "uniprot_kb": "P23944"}, {"Ensembl": "ENSGALG00000038787", "ortholog_type": "LDO", "panther_family": "PTHR24248", "taxid": 9031, "uniprot_kb": "A0A1D5PRZ3"}, {"ZFIN": "ZDB-GENE-090312-203", "ortholog_type": "LDO", "panther_family": "PTHR24248", "taxid": 7955, "uniprot_kb": "F1R2I5"}, {"WormBase": "WBGene00008890", "ortholog_type": "LDO", "panther_family": "PTHR24248", "taxid": 6239, "uniprot_kb": "G5EBX8"}], "uniprot_kb": "P25100"}, "pathway": {"kegg": [{"id": "hsa04020", "name": "Calcium signaling pathway - Homo sapiens (human)"}, {"id": "hsa04022", "name": "cGMP-PKG signaling pathway - Homo sapiens (human)"}, {"id": "hsa04080", "name": "Neuroactive ligand-receptor interaction - Homo sapiens (human)"}, {"id": "hsa04261", "name": "Adrenergic signaling in cardiomyocytes - Homo sapiens (human)"}, {"id": "hsa04270", "name": "Vascular smooth muscle contraction - Homo sapiens (human)"}, {"id": "hsa04970", "name": "Salivary secretion - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-373076", "name": "Class A/1 (Rhodopsin-like receptors)"}, {"id": "R-HSA-375280", "name": "Amine ligand-binding receptors"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-390696", "name": "Adrenoceptors"}, {"id": "R-HSA-416476", "name": "G alpha (q) signalling events"}, {"id": "R-HSA-416482", "name": "G alpha (12/13) signalling events"}, {"id": "R-HSA-500792", "name": "GPCR ligand binding"}], "wikipathways": [{"id": "WP117", "name": "GPCRs, Other"}, {"id": "WP455", "name": "GPCRs, Class A Rhodopsin-like"}, {"id": "WP536", "name": "Calcium Regulation in the Cardiac Cell"}, {"id": "WP58", "name": "Monoamine GPCRs"}]}, "pfam": "PF00001", "pharmgkb": "PA24597", "pharos": {"target_id": 4349, "tdl": "Tclin"}, "pir": ["I39369", "JH0447"], "prosite": "PS50262", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF245443", "relationship": "is"}, {"id": "GNF245444", "relationship": "is"}, {"id": "GNF245445", "relationship": "is"}, {"id": "GNF245446", "relationship": "is"}], "GNF_hs-GPCR_IDT-siRNA": [{"id": "GNF279840", "relationship": "is"}, {"id": "GNF279841", "relationship": "is"}, {"id": "GNF279842", "relationship": "is"}, {"id": "GNF279843", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079318", "relationship": "is"}, {"id": "GNF079319", "relationship": "is"}, {"id": "GNF079320", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051574", "relationship": "is"}, {"id": "GNF056340", "relationship": "is"}, {"id": "GNF061094", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071989", "relationship": "is"}, {"id": "GNF071990", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF093706", "relationship": "is"}, {"id": "GNF133364", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000020.11", "NC_060944.1"], "protein": "NP_000669.1", "rna": "NM_000678.4", "translation": {"protein": "NP_000669.1", "rna": "NM_000678.4"}}, "reporter": {"HG-U133_Plus_2": ["210960_at", "210961_s_at"], "HG-U95Av2": ["36728_at", "36729_g_at"], "HTA-2_0": "TC20000584.hg.1", "HuEx-1_0": "3895891", "HuGene-1_1": "8064779", "HuGene-2_1": "16916877"}, "retired": 149, "summary": "Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1D-adrenergic receptor. Similar to alpha-1B-adrenergic receptor gene, this gene comprises 2 exons and a single intron that interrupts the coding region. [provided by RefSeq, Jul 2008].", "symbol": "ADRA1D", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412260"}, "unigene": "Hs.557", "uniprot": {"Swiss-Prot": "P25100", "TrEMBL": "B0ZBE0"}, "wikipedia": {"url_stub": "Alpha-1D adrenergic receptor"}}